Citalopram
- Product NDC
- 31722-206
- 11-digit product format
- 317220206
- Labeler code
- 31722
- Product ID
- 31722-206_d16fcdcc-14b9-430f-9b14-900f8c2d3f84
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Citalopram
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals
- Application
- ANDA077534
- Marketing category
- ANDA
- Marketing start
- 2011-01-01
- Marketing end
- 0000-00-00
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 31722-206-01 | 2025-02-19 | C162847 | 48780-1 | 9d75b9d0-b2fc-f424-e053-dadaa90a57ce | b05c85d1-2474-4803-a0c0-585d5f764d4b |
| 31722-206-05 | 2025-02-19 | C162847 | 48780-1 | 9d75b9d0-b2fc-f424-e053-dadaa90a57ce | b05c85d1-2474-4803-a0c0-585d5f764d4b |
| 31722-206-10 | 2025-02-19 | C162847 | 48780-1 | 9d75b9d0-b2fc-f424-e053-dadaa90a57ce | b05c85d1-2474-4803-a0c0-585d5f764d4b |
| 31722-206-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b2fc-f424-e053-dadaa90a57ce | b05c85d1-2474-4803-a0c0-585d5f764d4b |
| 31722-206-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b2fc-f424-e053-dadaa90a57ce | b05c85d1-2474-4803-a0c0-585d5f764d4b |
| 31722-206-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b2fc-f424-e053-dadaa90a57ce | b05c85d1-2474-4803-a0c0-585d5f764d4b |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 31722-206-01 | EA - Each | 31722-206 | a216c042-0ce9-4206-85bb-0250f6623724 | 1 | 2012-07-24 |
| 31722-206-05 | EA - Each | 31722-206 | 54f14bff-9a02-4ac2-b86f-accf80da84cb | 1 | 2012-07-24 |